The proportion of patients with high expression of CD34 was significantly higher in patients with lymph node metastasis than in those without lymph metastasis (69.0% vs. 41.3%, χ2 = 5.452, P = 0.020). The gene discussed is CD34; the disease is metastatic malignant neoplasm in the lymph nodes.